Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-21

FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for the Lamotrigine Kit from OWP Pharmaceuticals, Inc. under ANDA078947, confirming the continued availability of lamotr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine Kit (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE KIT (LAMOTRIGINE)